EGFR kinase domain complexed with compound 20a

EGFR kinase domain complexed with compound 20a Descriptor: 4-({3-chloro-4-[3-(trifluoromethyl)phenoxy]phenyl}amino)-N-[2-(methylsulfonyl)ethyl]-8,9-dihydro-7H-pyrimido[4,5-b]azepine-6-carboxamide, Epidermal growth factor receptor, SULFATE ION Authors: Sogabe, S, Kawakita, Y. Deposit date: 2012-12-07 Release date: 2013-03-06 Last modified: 2023-11-08 Method: X-RAY DIFFRACTION (1.8 Å) Cite: Design and synthesis of novel pyrimido[4,5-b]azepine derivatives as HER2/EGFR dual inhibitors Bioorg.Med.Chem., 21, 2013

本数据集为表皮生长因子受体（Epidermal growth factor receptor, EGFR）激酶结构域与化合物20a的复合物，相关描述信息如下：配体化学结构为4-({3-氯-4-[3-(三氟甲基)苯氧基]苯基}氨基)-N-[2-(甲磺酰基)乙基]-8,9-二氢-7H-嘧啶并[4,5-b]氮杂卓-6-甲酰胺，体系包含硫酸根离子（SULFATE ION）。作者为Sogabe S与Kawakita Y，沉积日期为2012-12-07，发布日期为2013-03-06，最后修改日期为2023-11-08。实验方法采用X射线衍射（X-RAY DIFFRACTION），分辨率为1.8 Å。引用文献为《Design and synthesis of novel pyrimido[4,5-b]azepine derivatives as HER2/EGFR dual inhibitors》，刊载于《Bioorg.Med.Chem.》2013年第21卷。